Chair: Rubén Hernández, CIMA, Spain |
|
09:00 - 09:40 | Antisense Modulation of RNA Splicing for Rare Disease Therapyspan> Dr. Adrian Krainer, PhD, Cold Spring Harbor Laboratory, USA |
09:40 - 10:05 | Targeting RNA-processing in neurological disorders with antisense oligonucleotides and beyond Dr. Lorea Blázquez, PhD, Biogipuzkoa Health Research Institute, Spain |
10:05 - 10:30 | Therapeutic approaches for RNA splicing modulation in oncology Dr. Juan Valcárcel, PhD, Center for Genomic Regulation (CRG), Spain |
10:30 - 10:45 | Short talk 9 Development of splice Switching Oligonucleotides and therapeutic exosomes for liver pathologies Santiago Vernia, Institute of Biomedicine of Valencia, IBV CSIC, Spain |
10:45 - 11:00 | Short talk 10 Tumor suppressor role of RBM10 in lung adenocarcinoma is exerted through circular RNAs biogenesis regulation Ana Utrilla, Granada University, GENYO, Spain |
Chair: Fernando Pastor, CIMA, Spain |
|
11:30 - 12:10 | Local Immunotherapies based on IL-12 and IL-18 Dr. Ignacio Melero, MD, PhD, CIMA, Spain |
12:10 - 12:25 | Short talk 11 Targeting PD-1-positive lymphocytes with immunocytokines delivered by self-amplifying RNA enhances IL-12 antitumor activity Noelia Silva-Pilipich,Navarra University, Spain |
12:25 - 13:05 | Cancer Epitranscriptomics: from knowledge to applications Dr. Manel Esteller, MD, PhD, Instituto de Investigación contra la Leucemia Josep Carreras, Spain |
12:55 - 13:10 | Closing remarks |